Last reviewed · How we verify

NCT03779243

Treatment for Sleep Disturbance in Orthopaedic Trauma Patients

Completed NA Last updated 3 December 2021
What this trial tests

NA trial testing Melatonin 5mg and Sleep Education in Sleep Disturbance in 90 participants. Completed in 24 August 2021.

Timeline
7 January 2019
Primary endpoint
24 August 2021
24 August 2021

Quick facts

Lead sponsorStanford University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment90
Start date7 January 2019
Primary completion24 August 2021
Estimated completion24 August 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Stanford University

Who can join

18 and older, any sex, with Sleep Disturbance or Trauma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to test the efficacy of sleep treatment in human patients following traumatic injury. Specifically, the study will determine if treatment consisting of melatonin and education related to sleep habits are effective in treating sleep disturbance and improving sleep quality in Orthopaedic trauma patients. We hope to learn if melatonin and sleep education effectively improve sleep following traumatic injury, and improve outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sleep Disturbance

Currently open trials in the same condition.

Other Stanford University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03779243.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing